# Lifitegrast 5% for the Treatment of Dry Eye In Habitual Soft Contact Lens Wearers

> **NCT05505292** · PHASE4 · COMPLETED · sponsor: **State University of New York College of Optometry** · enrollment: 32 (actual)

## Conditions studied

- Dry Eye

## Interventions

- **DRUG:** Lifitegrast 5% Ophthalmic Solution
- **OTHER:** Lifitegrast Ophthalmic Solution Vehicle

## Key facts

- **NCT ID:** NCT05505292
- **Lead sponsor:** State University of New York College of Optometry
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-22
- **Primary completion:** 2023-05-15
- **Final completion:** 2023-05-15
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2025-01-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05505292

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05505292, "Lifitegrast 5% for the Treatment of Dry Eye In Habitual Soft Contact Lens Wearers". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT05505292. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
